Publications by authors named "Susan M Fox"

Claim this Profile
E
Efficacy of Linaclotide in Reducing Abdominal Symptoms of Bloating, Discomfort, and Pain: A Phase 3B Trial Using a Novel Abdominal Scoring System.
Lin Chang, Brian E Lacy, Baha Moshiree, Amy Kassebaum, Jessica L Abel, Susan M Fox

Am J Gastroenterol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Trial of 2 Delayed-Release Formulations of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation.
William D Chey, Gregory S Sayuk, Wilmin Bartolini, David S Reasner, Susan M Fox

Am J Gastroenterol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of linaclotide for opioid-induced constipation in patients with chronic noncancer pain syndromes from a phase 2 randomized study.
Darren M Brenner, Charles E Argoff, Susan M Fox, Wieslaw Bochenek, Patricia D'Astoli

Pain· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of linaclotide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation: pooled Phase 3 analysis.
Judy W Nee, Jeffrey M Johnston, Elizabeth P Shea, Courtney E Walls, Kenneth Tripp, Susan M Fox

Expert Rev Gastroenterol Hepatol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-Dose Linaclotide (72 μg) for Chronic Idiopathic Constipation: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial.
Philip Schoenfeld, Brian E Lacy, William D Chey, Anthony J Lembo, Caroline B Kurtz, Susan M Fox

Am J Gastroenterol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Linaclotide in Chronic Idiopathic Constipation Patients with Moderate to Severe Abdominal Bloating: A Randomized, Controlled Trial.
Brian E Lacy, Ron Schey, Steven J Shiff, Bernard J Lavins, Susan M Fox

PLoS One· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation.
Satish Rao, Anthony J Lembo, Steven J Shiff, Bernard J Lavins, Mark G Currie, Susan M Fox

Am J Gastroenterol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two randomized trials of linaclotide for chronic constipation.
Anthony J Lembo, Harvey A Schneier, Steven J Shiff, Caroline B Kurtz, James E MacDougall, Susan M Fox

N Engl J Med· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis